Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Inventory (2016 - 2025)

Historic Inventory for Cryo Cell International (CCEL) over the last 12 years, with Q3 2025 value amounting to $655254.0.

  • Cryo Cell International's Inventory fell 1040.61% to $655254.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $655254.0, marking a year-over-year decrease of 1040.61%. This contributed to the annual value of $657703.0 for FY2024, which is 1445.93% down from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Inventory is $655254.0, which was down 1040.61% from $676764.0 recorded in Q2 2025.
  • Cryo Cell International's Inventory's 5-year high stood at $1.1 million during Q3 2023, with a 5-year trough of $655254.0 in Q3 2025.
  • Its 5-year average for Inventory is $821633.2, with a median of $851230.0 in 2022.
  • In the last 5 years, Cryo Cell International's Inventory surged by 1561.98% in 2023 and then tumbled by 3118.94% in 2024.
  • Cryo Cell International's Inventory (Quarter) stood at $921213.0 in 2021, then dropped by 7.6% to $851230.0 in 2022, then dropped by 9.67% to $768877.0 in 2023, then decreased by 14.46% to $657703.0 in 2024, then dropped by 0.37% to $655254.0 in 2025.
  • Its Inventory stands at $655254.0 for Q3 2025, versus $676764.0 for Q2 2025 and $730467.0 for Q1 2025.